Related Experiment Video
Updated: May 22, 2026

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
Published on: July 4, 2018
Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling
Shu Zhang1, Xiaoning Zeng, Haiwei Yang
1Clinical Research Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background:
Mast cell tryptase can stimulate peripheral mononuclear cells activation to cause widespread inflammation. However, the influence of tryptase on microglia, the resident immune cells in the brain, remains uninvestigated. Since microglia plays a pivotal role in immune surveillance of CNS, we studied the effect of tryptase on microglia activation.
Methods:
Induction of microglia activation by tryptase was examined with primary cultured microglia. TNF-alpha and IL-6 was measured with a commercial ELISA kit. Intracellular ROS was determined by dichlorodihydrofluorescein oxidation. Mitochondrial membrane potential was assessed with the MitoProbe™ JC-1 assay kit. And MAPK and NF-kappa B phosphorylation were evaluated by Western blot.
Results:
We found that tryptase stimulated microglia activation and subsequently produced proinflammatory factors TNF-alpha, IL-6 and ROS. Inhibition of PAR-2 activation reduced tryptase-induced TNF-alpha, IL-6 and ROS production, and mitochondrial membrane potential loss in microglia. Among the three members of MAPK pathway, ERK and p38, but not JNK mediated tryptase-induced microglia activation. Inhibition of PAR-2 suppressed tryptase-induced ERK and p38 MAPK pathway activation in microglia. Tryptase also activated NF-kappa B within 30 min, and ammonium pyrrolidinedithiocarbamate, an inhibitor of NF- kappa B, reduced tryptase-induced TNF-alpha and IL-6 release.
Conclusions:
Our results suggest that tryptase can induce microglia activation and pro-inflammatory mediator release via PAR-2-MAPK-NF-kappa B signaling pathway, which will contribute to the development of microglia-mediated inflammation in brain.
Insights
Mast cell tryptase activates brain microglia, releasing inflammatory factors via the PAR-2-MAPK-NF-kappa B pathway. This finding sheds light on microglia-mediated brain inflammation.
Area of Science:
- Neuroimmunology
- Cellular and Molecular Neuroscience
Background:
- Mast cell tryptase is known to activate peripheral immune cells, contributing to inflammation.
- The role of tryptase in activating microglia, the brain's resident immune cells, was previously uninvestigated.
- Microglia are crucial for central nervous system (CNS) immune surveillance.
Purpose of the Study:
- To investigate the effect of mast cell tryptase on microglia activation.
- To elucidate the signaling pathways involved in tryptase-induced microglia activation.
Main Methods:
- Primary microglia cultures were used to examine tryptase-induced activation.
- Pro-inflammatory factors (TNF-alpha, IL-6), reactive oxygen species (ROS), and mitochondrial membrane potential were measured.
- MAPK and NF-kappa B phosphorylation were assessed via Western blot.
Main Results:
- Tryptase stimulated microglia activation, leading to the release of TNF-alpha, IL-6, and ROS.
- Protease-activated receptor-2 (PAR-2) activation was involved in tryptase-induced inflammatory mediator release and mitochondrial dysfunction.
- Tryptase-induced microglia activation was mediated by ERK and p38 MAPK pathways and NF-kappa B activation via PAR-2.
Conclusions:
- Tryptase induces microglia activation and pro-inflammatory mediator release through the PAR-2-MAPK-NF-kappa B signaling pathway.
- This mechanism contributes to the development of microglia-mediated inflammation in the brain.
- Targeting this pathway may offer therapeutic strategies for neuroinflammatory conditions.
Related Concept Videos
MAPK Signaling Cascades
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Inflammation
The Tumor Microenvironment
Amplifying Signals via Second Messengers
